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S U M M A R Y
Objective: To investigate the correlation of single nucleotide polymorphisms (SNPs) in SFTPA1 and
SFTPA2 genes encoding pulmonary surfactant protein A (SP-A) with the susceptibility to pulmonary
tuberculosis (PTB) in the Han population in China.
Methods: This study included 248 patients with active PTB (case group) and 124 normal individuals
(control group). SNPs at loci aa19, aa50, aa62, aa133, and aa219 of SFTPA1, and at loci aa9, aa91, aa140,
and aa223 of SFTPA2 were analyzed with PCR. Multivariate logistic regression analysis was used to
identify the correlation of age, sex, and SNPs with PTB.
Results: The frequencies of the G allele at aa91 and T allele at aa140 in SFTPA2 were signiﬁcantly higher
in the case group than in the control group (p = 0.0002 and p = 0.045). The distribution of haplotype
CGAAC in SFTPA1 was signiﬁcantly lower in the case group than in the control group (p = 0.025).
In SFTPA2, the distributions of haplotypes 1A6, 1A10, 1A9, and 1A2 were higher (all p < 0.05), but the
distributions of haplotypes 1A13, 1A5, and 1A12were lower in the case group than in the control group (all
p < 0.05). When SFTPA1 and SFTPA2 were combined and analyzed, haplotype 6A11–1A8 was only found
in the case group (4.1%, p = 0.001 compared with the control group), but the distribution of haplotype
CGAAC-1A0 or 6A4–1A12was signiﬁcantly lower in the case group than in the control group (all p < 0.05).
Conclusions: SNP in SP-A is associated with PTB in the Han population in China. The G allele at aa91, T
allele at aa140, and haplotype 6A11–1A8 are risk factors for PTB, but haplotype CGAAC–1A0 and
6A4–1A12 are protective factors for PTB.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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Pulmonary tuberculosis (PTB) is caused by infection with
Mycobacterium tuberculosis through respiratory droplets. At
present, PTB remains a serious threat to people’s lives.1 Although
a third of the world’s population is infected with M. tuberculosis,
only 10% of these infected individuals will develop active PTB,
suggesting that PTB may be associated with immunity and genetic
susceptibility.2,3* Corresponding authors. Tel.: +86 371 66658161; fax: +86 371 66658161.
E-mail addresses: zdxw55@163.com (X.-w. Li), chenhui@zzu.edu.cn (H. Chen).
http://dx.doi.org/10.1016/j.ijid.2014.03.1395
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Pulmonary surfactant protein A (SP-A), a type of immunoreac-
tive protein secreted by type II alveolar epithelial cells, is an
important part of the natural immune defenses in the human
respiratory system and plays an important role in immune defense,
inﬂammatory reactions, and allergic reactions.4–7 SP-A is the ﬁrst
line of defense against M. tuberculosis, because M. tuberculosis
mainly enters through the respiratory tract. The human SP-A gene
is located in 10q22–q23.1 and encodes 248 amino acids.8 The SP-A
gene consists of two functional genes, SFTPA1 and SFTPA2.9 There
are nine single nucleotide polymorphism (SNP) sites located in the
SP-A gene: ﬁve in SFTPA1, encoding amino acid residues 19, 50, 62,
133, and 219, and four in SFTPA2, encoding amino acid residues 9,
91, 140, and 223.10 Based on these, many haplotypes develop;ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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SFTPA2 as 1Am.11 A SNP could lead to a change in protein structure
and function, causing different susceptibility to tuberculosis.
2. Materials and methods
All study methods were approved by the Institutional Review
Board and Ethics Committee of the First Afﬁliated Hospital of
Zhengzhou University. All the subjects enrolled in the study gave
formal written consent to participate.
2.1. Subjects
A total of 248 patients diagnosed with active tuberculosis for
the ﬁrst time, in accordance with the diagnostic criteria for PTB
(WS288–2008)12 of the Ministry of Health of the People’s
Republic of China (2008), were enrolled in the study. These
patients were treated at Henan Xinxiang, Anyang, and Zhengz-
hou tuberculosis prevention and treatment centers between
October 2011 and November 2011. The inclusion criteria were:
(1) age >18 years; (2) Han ethnicity, and (3) from China. Patients
with HIV infection, diabetes mellitus, or who had been
administered adrenal cortex hormones or immunosuppressive
agents were excluded. Of the 248 patients, 163 were men and 85
were women; their mean age was 38.9  17.6 years.
Another 124 individuals served as a control group. These
patients had a history of M. tuberculosis exposure and a normal
chest X-ray. In individuals with a bacille Calmette–Gue´rin (BCG)
mark, the puriﬁed protein derivative (PPD) tuberculin test
indicated an average diameter of PPD callosity reaction
10 mm. In patients without a BCG mark and BCG vaccination
history, the PPD tuberculin test indicated an average diameter of
PPD callosity reaction 5 mm. Of the 124 control group patients,
70 were men and 54 women; their mean age was 36.0  15.7 years.
2.2. DNA extraction
A total of 2 ml of blood was collected by venipuncture from
each subject, with 2% ethylenediaminetetraacetic acid
disodium salt (EDTA-Na2) as anticoagulant. Genomic DNA was
extracted from peripheral blood mononuclear cells with a
phenol–chloroform extraction protocol, and then detected
using an ultraviolet spectrophotometer.
2.3. SNPs in the SP-A gene
SNPs at loci aa19, aa50, aa62, aa133, and aa219 in SFTPA1,
and at loci aa9, aa91, aa140, and aa223 in SFTPA2 were analyzed
by PCR with genomic DNA as templates. Primer sequences were
from GenBank and were synthesized by Shanghai Sangon
Company. At the same time, Human adenomatous polyposis
coli (APC) and Human leukocyte antigen-DRB1(HLA-DRB1)
served as controls. PCR was performed as described previous-
ly.13,14 PCR products underwent 2% agarose gel electrophoresis
and were then stained with EB (ethidium bromide) followed by
observation under a vitalight lamp with a gel imager. Two
samples from each of three different genotypes in each locus
were detected by Shanghai Biological Technology Co. Ltd.
2.4. Statistical analysis
Genotype frequency and gene frequency were analyzed by
data entry into an Excel table. Hardy–Weinberg equilibrium,
allele frequencies, haplotype, and linkage disequilibrium were
analyzed with SHEsis software (http://analysis.bio-x.cn/myAna-
lysis.php). The statistical analysis was performed using SPSSv. 17.0 software (SPSS Inc., Chicago, IL, USA). The Chi-square
test was used for comparisons of allele and genotype frequen-
cies between the case group and control group. Odds ratios (OR)
with 95% conﬁdence intervals (95% CI) were calculated to
identify the relationship between SNPs and PTB. Multivariate
logistic regression analysis was used to investigate the correla-
tion of age, sex, and SNPs with PTB.
3. Results
3.1. SNPs at nine loci in the SP-A gene
SNPs at the nine loci in the SP-A gene were obtained by
sequence-speciﬁc ampliﬁcation PCR (PCR-SSP). Hardy–Weinberg
equilibrium indicated that the genotype distribution was consis-
tent in both groups (P > 0.05).
There were no statistical differences in gene frequency or
genotype frequency at loci aa19, aa50, aa62, aa133, and aa219 in
SFTPA1 between the case group and control group (all P > 0.05).
The frequencies of the G allele at aa91 (0.627 vs. 0.484) and T allele
at aa140 (0.312 vs. 0.242) in SFTPA2 were signiﬁcantly higher in
the case group than in the control group (p = 0.0002, OR 1.792, 95%
CI 1.318–2.439, and p = 0.045, OR 1.425, 95% CI 1.006–2.016,
respectively). However, in SFTPA2, there were no statistical
differences in gene frequency or genotype frequency at loci aa9
and aa223 between the case group and the control group (all
p > 0.05) (Table 1).
3.2. Haplotypes in the SP-A gene
The distribution of haplotype CGAAC in SFTPA1 was signiﬁ-
cantly lower in the case group (0.035) than in the control group
(0.072) (p = 0.025, OR 0.456, 95% CI 0.235–0.920). In SFTPA2, the
distributions of haplotypes 1A6, 1A10, 1A9, and 1A2 were all higher
(all p < 0.05), but the distributions of haplotypes 1A13, 1A5, and
1A12 were all lower in the case group than in the control group (all
p < 0.05). When SFTPA1 and SFTPA2 were combined and analyzed,
haplotype 6A11–1A8 was only found in the case group (4.1%;
p = 0.001 compared with control group) and 6A4–1A12 was only
found in the control group (4.2%; p < 0.05 compared with case
group), but the distribution of haplotype CGAAC-1A0 was
signiﬁcantly lower in the case group (0.006) than in the control
group (0.044) (p = 0.001) (Table 2).
3.3. Analysis of the SP-A gene stratiﬁed by sex
In male patients, the frequencies of aa91-C in SFTPA2 and
haplotype 6A3–1A12 were signiﬁcantly higher (p = 0.009 and
p = 0.033), but haplotypes 6A3–1A0, 6A4–1A12, CGAAC-1A0,
6A5–1A, and 6A3–1A5 were signiﬁcantly lower (all p < 0.05) in
the case group than in the control group. In female patients, the
frequencies of aa9-A and aa91-C and haplotypes 6A2–1A0 and
6A11–1A8 were signiﬁcantly higher (all p < 0.05), but haplotypes
6A3–1A0, 6A2–1A12, and CGAAC-1A12 were signiﬁcantly lower
in the case group than in the control group (all p < 0.05). The loci
and haplotypes in the SP-A gene with a statistical difference in
distribution frequency between the case group and control group
for males and females are shown in Tables 3 and 4, respectively.
3.4. Multivariate logistic regression analysis of the correlation of age,
sex, and SNPs with pulmonary tuberculosis
The multivariate logistic regression model was built with sex,
age, and nine SNP loci as variables. Multivariate logistic regression
analysis indicated that aa91 and aa140 were included in the
regression equation (both p < 0.05; OR 1.883, 95% CI 1.367–2.592,
Table 1
Comparison of SNPs in the pulmonary surfactant protein A gene between the case group and the control group
SNP Group Genotype
and genotype
frequency
p-Value Gene
frequency
p-Value OR
(95% CI)
aa19
(rs1059047)
CC CT TT C T
Case 2 (0.008) 73 (0.294) 173 (0.698) 0.182 77 (0.155) 419 (0.845) 0.086 0.710
(0.480–1.051)
Control 2 (0.016) 47 (0.379) 75 (0.605) 51 (0.206) 197 (0.794)
aa50
(rs1136451)
CC CG GG
Case 119 (0.480) 101 (0.407) 28 (0.113) 0.830 339 (0.683) 157 (0.317) 0.956 1.009
(0.728–1.400)
Control 61 (0.492) 47 (0.379) 16 (0.129) 169 (0.681) 79 (0.319)
aa62
(rs1136451)
AA AG GG A G
Case 142 (0.573) 93 (0.375) 13 (0.052) 0.269 377 (0.760) 119 (0.240) 0.856 1.033
(0.725–1.474)
Control 74 (0.597) 39 (0.315) 11 (0.089) 187 (0.754) 61 (0.246)
aa133
(rs1059057)
AA AG GG A G
Case 235 (0.948) 12 (0.048) 1 (0.004) 0.235 482 (0.972) 14 (0.028) 0.074 0.280
(0.063–1.241)
Control 122 (0.984) 2 (0.016) 0 (0.000) 246 (0.992) 2 (0.008)
aa219
(rs4253527)
CC CT TT C T
Case 148 (0.597) 89 (0.359) 11 (0.044) 0.079 385 (0.776) 111 (0.224) 0.201 1.258
(0.885–1.788)
Control 71 (0.573) 40 (0.323) 13 (0.105) 182 (0.734) 66 (0.266)
aa9
(rs1059046)
AA AC CC A C
Case 90 (0.363) 130 (0.524) 28 (0.113) 0.612 310 (0.625) 186 (0.375) 0.568 0.885
(0.643–1.217)
Control 48 (0.387) 66 (0.532) 10 (0.081) 162 (0.653) 86 (0.347)
aa91
(rs17886395)
CC CG GG C G
Case 30 (0.121) 125 (0.504) 93 (0.375) <0.001 185 (0.373) 311 (0.627) 0.0002a 1.792
(1.318–2.439)
Control 38 (0.307) 52 (0.419) 34 (0.274) 128 (0.516) 120 (0.484)
aa140
(rs1965707)
CC CT TT C T
Case 135 (0.544) 71 (0.286) 42 (0.169) 0.110 341 (0.688) 155 (0.312) 0.045a 1.425
(1.006–2.016)
Control 75 (0.605) 38 (0.306) 11 (0.089) 188 (0.758) 60 (0.242)
aa223
(rs1965708)
AA AC CC A C
Case 9 (0.036) 90 (0.363) 149 (0.601) 0.243 108 (0.218) 388 (0.782) 0.708 0.933
(0.648–1.343)
Control 9 (0.073) 39 (0.315) 76 (0.613) 57 (0.230) 191 (0.770)
SNP, single nucleotide polymorphisms; OR, odds ratio; CI, conﬁdence interval.
a Signiﬁcant.
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and the other seven loci failed to be included in the regression
equation.
4. Discussion
With the increase in number of people infected with the
tubercle bacillus, tuberculosis has received great attention.
M. tuberculosis, a type of intracellular pathogen, can enter
macrophages to survive and maintain a pathogenic cycle.15 Hosts
may carry M. tuberculosis for a long time and rarely suffer from
tuberculosis after infection; however, when the host’s immunity
decreases, a strong proliferation of the latent M. tuberculosis may
lead to tuberculosis. This is an important reason why HIV-infected
people and older people are liable to catch tuberculosis. The host’s
immunity is strongly associated with the onset and prognosis of
tuberculosis.16 M. tuberculosis infection mainly causes type IV
hypersensitivity, a delayed type hypersensitivity (DTH), in the
human body. Macrophages are the ﬁnal effector cells during
DTH and play an important role in infection and the onset ofM. tuberculosis.17 PTB is caused by infection with M. tuberculosis
mainly through respiratory droplets.
SP-A, a type of natural immune factor, acts on the
glycoprotein present on the cell wall of M. tuberculosis and
mannose receptor on the surface of macrophages to enhance the
uptake of M. tuberculosis, acting as a bridge between macrophages
and M. tuberculosis.18 SP-A can increase the concentrations
of superoxide radicals and NO, allowing macrophages to kill
M. tuberculosis.19 SP-A may increase the expression levels of
other natural immune receptors such as scavenger receptor (SR-
A)20 and complement receptor (CR3),21 to induce the phagocytic
effects of macrophages on M. tuberculosis. SP-A may also regulate
Toll-like receptor (TLR) to be involved in the inﬂammatory
reaction caused by M. tuberculosis.22 In vivo comparative tests
between M. tuberculosis-infected macrophages and non-infected
macrophages and tests on living mice infected with M. tuberculosis
have indicated that SP-A has a variety of effects,23–25 but many
mechanisms remain to be investigated further.
Polymorphism of the SP-A gene is named SNP, because it is
mainly caused by a single nucleotide mutation. SNP, one of the
most common human genetic variations, accounts for more than
Table 2
Comparison of haplotypes in the pulmonary surfactant protein A gene between the
case group and the control groupa
Haplotype Case group Control group p-Value OR (95% CI)
SFTPA1
TCAAC (6A3) 184 (0.371) 83 (0.336) 0.346 1.168 (0.845–1.613)
TGAAC (6A2) 126 (0.254) 54 (0.217) 0.253 1.237 (0.859–1.782)
TCGAT (6A4) 82 (0.166) 44 (0.178) 0.682 0.919 (0.614–1.376)
CCAAC (6A11) 34 (0.068) 20 (0.080) 0.534 0.833 (0.468–1.483)
CGAACb 17 (0.035) 18 (0.072) 0.025c 0.465 (0.235–0.920)
CCGAT (6A5) 15 (0.031) 8 (0.033) 0.873 0.932 (0.392–2.217)
SFTPA2
AGCC (1A0) 133 (0.267) 70 (0.283) 0.660 0.927 (0.659–1.302)
ACCC (1A12) 72 (0.145) 52 (0.208) 0.029c 0.645 (0.434–0.957)
CGCA (1A8) 44 (0.089) 19 (0.076) 0.557 1.183 (0.674–2.076)
CGCC (1A2) 37 (0.074) 9 (0.034) 0.031c 2.266 (1.058–4.854)
ACTC (1A7) 36 (0.072) 13 (0.053) 0.325 1.384 (0.723–2.650)
AGTC (1A9) 36 (0.072) 5 (0.020) 0.003c 3.827 (1.474–9.935)
CCCC (1A) 34 (0.069) 25 (0.102) 0.114 0.649 (0.379–1.113)
CGTC (1A6) 24 (0.049) 0 (0.000) <0.001c –
CCTA (1A10) 18 (0.036) 0 (0.000) 0.003c –
CCTC (1A5) 17 (0.034) 17 (0.070) 0.026c 0.467 (0.235–0.928)
CGTA (1A1) 11 (0.021) 11 (0.046) 0.062 0.453 (0.193–1.063)
ACTA (1A13) 0 (0.000) 11 (0.044) <0.001c 0.006 (0.000–0.074)
SFTPA1 + SFTPA2
6A2–1A0 64 (0.129) 26 (0.105) 0.255 1.326 (0.814–2.160)
6A3–1A0 58 (0.117) 31 (0.125) 0.906 0.972 (0.607–1.556)
6A2–1A12 34 (0.068) 22 (0.087) 0.437 0.800 (0.454–1.407)
6A4–1A8 25 (0.051) 16 (0.065) 0.519 0.809 (0.424–1.543)
6A4–1A7 21 (0.042) 8 (0.030) 0.387 1.452 (0.621–3.395)
6A11–1A8 20 (0.041) 0 (0.000) 0.001c –
6A4–1A7 18 (0.036) 5 (0.022) 0.262 1.739 (0.654–4.624)
6A3–1A9 16 (0.033) 6 (0.023) 0.382 1.540 (0.581–4.085)
6A3–1A8 15 (0.029) 14 (0.055) 0.106 0.540 (0.253–1.152)
6A4–1A5 11 (0.023) 9 (0.038) 0.284 0.620 (0.257–1.497)
CGAAC-1A0 3 (0.006) 11 (0.044) 0.001c 0.146 (0.042–0.514)
6A4–1A12 0 (0.000) 10 (0.042) <0.001c 0.000 (0.000–0.007)
OR, odds ratio; CI, conﬁdence interval.
a For both the case group and control group, haplotypes with a distribution
frequency of less than 0.03 were excluded in this study.
b Indicates the haplotype that was found in this study and has not been named.
c Signiﬁcant.
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have one SNP. Mutation may occur in any base of genomic DNA. A
SNP in the coding region may lead to changes in the base sequence,
which alter the protein sequence, thereby affecting the protein
functions. A SNP in the control region is likely to regulate the level
of the translated protein. Changes in the level or quality of these
transfected proteins usually affect the biocharacteristics of these
proteins, which is the molecular mechanism of genetic suscepti-
bility in many diseases. In this study, of the nine SNP loci in the SP-
A gene, a synonymous mutation occurred in the loci aa62 and
aa133 in SFTPA1 and locus aa140 in SFTPA2, and a missense
mutation occurred in the other six loci. These missense mutations
affect mRNA expression, resulting in changes in the structure and
function of the SP-A protein, which is associated with the
susceptibility to PTB.Table 3
Comparison of SNPs in the pulmonary surfactant protein A gene between the case gro
Locus and haplotype Case group Control group 
aa91–G (rs17886395) 204 (0.630) 83 (0.506) 
6A3–1A12 15 (0.047) 2 (0.011) 
6A3–1A0 11 (0.034) 13 (0.080) 
6A4–1A12 0 (0.000) 10 (0.059) 
CGAAC-1A0 4 (0.012) 8 (0.049) 
6A5–1A 0 (0.000) 6 (0.039) 
6A3–1A5 0 (0.000) 5 (0.030) 
SNP, single nucleotide polymorphisms; OR, odds ratio; CI, conﬁdence interval.Polymorphism of the SP-A gene is associated with a variety of
diseases.26 A SNP in the second exon and intron 2 in the collagen
area of SFTPA1 and SFTPA2 proteins can increase the incidence of
allergic bronchitis.27 aa223-A encoding lysine is related to the
respiratory tract infection caused by respiratory syncytial virus-
es.28 In the SFTPA1 gene, transversion of arginine to tryptophan at
aa219-T is strongly associated with congenital pulmonary ﬁbro-
sis.29 Polymorphism in SFTPA1 and SFTPA2 genes is related to the
susceptibility to neonatal respiratory distress syndrome.30,31 It is
reported that polymorphism in the SP-A gene is correlated with
tuberculosis in Ethiopia, Mexico, and Indian.32–34 Malik et al.32
investigated 226 patients with tuberculosis in 181 families in
Ethiopia and found that the A allele at aa62 and T allele at aa219 in
SFTPA1, and the C allele at aa91 and C allele at aa223 in SFTPA2,
were correlated with tuberculosis; it was also found that 1A3 in ﬁve
haplotypes of SFTPA1 and in nine haplotypes of SFTPA2 is a
susceptibility gene for PTB. Floros et al.33 also found 1A3 in SFTPA2
to be a risk factor for PTB in a Mexican population. Madan et al.34
reported locus aa91 to be related to PTB in an Indian population.
The susceptibility genes for tuberculosis vary according to
ethnic groups and regions. Little research has been done on the
correlation of the SP-A gene with PTB in the Han population in
China. In this study, we observed SNPs at nine loci in the SP-A gene
in both the patients with PTB (n = 248) and individuals with a
history of M. tuberculosis exposure and normal chest X-ray
(n = 124). Our results indicated that the G allele at aa91 and T
allele at aa140 in SFTPA2 were signiﬁcantly higher in the case
group than in the control group (p = 0.0002 and p = 0.045),
suggesting that the two loci aa91 and aa140 are related to PTB
in the Han population in China. The G allele at aa91 (OR 1.792, 95%
CI 1.318–2.439) and T allele at aa140 (OR 1.425, 95% CI 1.006–
2.016) may be risk factors for PTB in the Han population in China.
There were no statistical differences in gene frequency or genotype
frequency at two loci (aa9 and aa223) in SFTPA2 and ﬁve loci (aa19,
aa50, aa62, aa133 and aa219) in SFTPA1 between the case group
and the control group (all p > 0.05), suggesting that these loci are
not related to PTB in the Han population in China.
In this study, aa91–G (Pro-A1a) was found to be associated with
PTB in the Han population, which is consistent with the results
reported by Madan et al.34 and Malik et al.32 This may be the
transversion of proline to alanine at aa91 in SP-A. The pyrrole ring
in proline can stabilize the triple helical structure of the SP-A
protein. When proline is replaced by alanine, the triple helical
structure of the SP-A protein is unstable, affecting the normal
function of SP-A.35 A synonymous mutation occurred at aa140 in
SFTPA2. The SNP at aa140 may interfere with the shear and
modiﬁcation of mRNA because the locus aa140 is located near the
splicing region of introns and exons, affecting the function of SP-A.
It has been conﬁrmed that a synonymous mutation can affect
mRNA splicing, resulting in severe function disorder in spinal
muscular atrophy, frontotemporal dementia, and Parkinsonism.36
Synonymous mutation is of great signiﬁcance for human health,
individual therapy, and susceptibility to disease.37 Malik et al.32up and the control group in male patients with pulmonary tuberculosis
Chi-square p-Value OR (95% CI)
6.86 0.009 1.658 (1.134–2.427)
4.546 0.033 4.615 (0.990–21.505)
4.25 0.039 0.427 (0.186–0.979)
17.161 <0.001 0.002 (0.000–0.025)
5.766 0.016 0.245 (0.071–0.844)
12.101 0.001 0.328 (0.289–0.372)
9.369 0.002 0.329 (0.290–0.374)
Table 5
Variables entering into the regression equation after multivariate logistic regression analysis
Variable B value Standard
error
Wald
Chi-square
value
Degrees
of freedom
p-Value OR OR (95% CI)
Lower limit Upper limit
aa91 0.633 0.163 15.040 1 <0.001 1.883 1.367 2.592
aa140 0.365 0.163 5.004 1 0.025 1.441 1.046 1.984
Constants 1.211 0.465 6.766 1 0.009 0.298
OR, odds ratio; CI, conﬁdence interval.
Table 4
Comparison of SNPs in the pulmonary surfactant protein A gene between the case group and the control group in female patients with pulmonary tuberculosis
Locus and haplotype Case group Control group Chi-square p-Value OR (95% CI)
aa9–C (rs1059046) 74 (0.430) 24 (0.286) 4.989 0.026 1.887 (1.076–3.311)
aa91–G (rs17886395) 107 (0.622) 37 (0.440) 7.565 0.006 2.092 (1.232–3.546)
6A2–1A0 34 (0.199) 6 (0.068) 9.011 0.003 3.863 (1.520–9.818)
6A3–1A0 12 (0.070) 18 (0.218) 9.746 0.002 0.301 (0.138–0.659)
6A2–1A12 8 (0.046) 11 (0.134) 5.105 0.024 0.347 (0.134–0.898)
6A11–1A8 7 (0.042) 0 (0.000) 3.971 0.046 1.509 (1.381–1.647)
CGAAC-1A12 0 (0.000) 5 (0.054) 8.554 0.003 0.315 (0.262–0.378)
SNP, single nucleotide polymorphisms; OR, odds ratio; CI, conﬁdence interval.
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with PTB in Ethiopians.
In this study, haplotype CGAAC in the SFTPA1 gene was found in
more than 5% of the normal group, but it has not been found in
American patients and has not been named. Haplotype CGAAC in
the SP-A gene was found and accounted for 8.2% in a Caucasian
population.38 Differences in the frequencies of haplotypes in
SFTPA1 and SFTPA2 genes between the Han population, Americans,
Finns, and Caucasians suggests that polymorphism in the human
SP-A gene varies according to the ethnic group and region. In this
study, the distribution of haplotype CGAAC in SFTPA1 was
signiﬁcantly lower in the case group (0.035) than in the control
group (0.072) (p = 0.025, OR 0.456, 95% CI 0.235–0.920); in SFTPA2,
the distribution of haplotypes 1A6, 1A10, 1A9 and 1A2 were higher
(all p < 0.05), but the distribution of haplotypes 1A13, 1A5, 1A12,
and 1A11were lower in the case group than in the control group (all
p < 0.05). The results above suggest that haplotypes 1A6, 1A10, 1A9,
and 1A2 in SFTPA2 are risk factors for PTB, but haplotype CGAAC in
SFTPA1 and haplotypes 1A13, 1A5, 1A12, or 1A11 in SFTPA2 are
protective factors for PTB in the Han population in China. In this
study, when SFTPA1 and SFTPA2 were combined and analyzed,
haplotype 6A11-1A8 was only found in the case group (4.1%;
p = 0.001 compared with control group), but the distributions of
CGAAC-1A0 and 6A4–1A12 were signiﬁcantly higher in the
control group than in the case group (all p < 0.05), suggesting
that 6A11–1A8 is a risk factor, and CGAAC-1A0 and 6A4–1A12 are
protective factors for PTB in the Han population in China.
Analysis of the SP-A gene stratiﬁed by sex indicated that the
frequency of aa91–C in both males and females was signiﬁcantly
higher in the case group than in control group (all p < 0.05),
suggesting that the G allele at aa91 is a risk factor for PTB in the
Han population in China and that the correlation of the G
allele at aa91 with PTB is not associated with sex. In females, the
frequency of aa9-C was signiﬁcantly higher in the case group
than in the control group (p = 0.026, OR 1.877, 95% CI 1.076–
3.311), suggesting that aa9-C is a risk factor for PTB in the male
Han population in China. For haplotypes, 6A3–1A12 (OR 4.615) is
a risk factor in the male Han population, and 6A2–1A0 (OR 3.863)
and 6A11–1A8 (OR 1.509) are risk factors in the female Han
population. Haplotypes 6A3–1A0, 6A4–1A12, CGAAC–1A0, 6A5–
1A, and 6A3–1A5 are protective factors for PTB in the male Han
population in China, and haplotypes CGAAC-1A12, 6A2–1A12, and6A3–1A0 are protective factors for PTB in the female Han
population in China. The different loci in the SP-A gene have
different effects on the pathogenesis of PTB, which may be
associated with sex; this needs to be investigated further.
In this study, the loci and haplotypes associated with PTB
were found mostly to be located in the SFTPA2 gene, suggesting
that the effects of the SFTPA2 gene on PTB are stronger than
those of SFTPA1. This may be because SFTPA2 encoding products
have higher bioactivity than those of SFTPA1, and linkage
disequilibrium analysis indicates that the SFTPA2 gene is a
more active recombinant region. Although only about 10 amino
acid residues in the products are different between SFTPA1
and SFTPA2, the biological function of SFTPA2 encoding products
is markedly stronger than that of SFTPA1. This may be because
SFTPA2 encoding amino acids are located in the core of the
structural domain of the SP-A encoding protein, playing a
more important role in the structure and function of the SP-A
encoding protein. The SNP in SFTPA2, especially in the
complementarity-determining region (CDR) region, can affect
the combination of immune molecules with M. tuberculosis, and
then interfere with inﬂammatory reactions and tissue recon-
struction after M. tuberculosis infection.
PTB is associated not only with the number and virulence of
the infecting M. tuberculosis, but also the host’s immunity and
gene expression. Studies on the immunological mechanisms and
genetic susceptibility of tuberculosis are important, because they
will help to clarify the pathogenic mechanism of M. tuberculosis,
screen the susceptible population, explore anti-tuberculosis
methods, and develop vaccines against tuberculosis. Since the
pathogenesis of PTB is complex, further large sample size studies
investigating immunology and proteomics are needed.
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